Alzheimer’s Experts Review Progress and Challenges in a ‘Transformative Moment’ 01/03/2024 Sophia Samantaroy WASHINGTON, DC – When US Senator Amy Klobuchar’s father, the late Jim Klobuchar, was diagnosed with Alzheimer’s disease, the noted Minnesota newspaper columnist gradually stopped recognizing her – although he retained “a kind of savoir faire” to the very end with words, jokes and storytelling based on the decades of “lines enmeshed in his memory,” […] Continue reading -> India Pushes Back To Protect Patient Access to Generic Medicines 15/02/2024 Disha Shetty PUNE, INDIA – Commerce minister Sunil Barthwal has clarified that India will not sign a new trade agreement with the European Free Trade Association (EFTA) that would limit access by the country’s thriving generic medicine industry to new drug formulations for critical diseases. India is currently negotiating a new trade deal with the EFTA, which […] Continue reading -> WHO Issues First-Ever List of Antimicrobials with Category “For Use in Humans Only” 13/02/2024 Sophia Samantaroy The WHO has released a first-ever list of 21 antimicrobials earmarked as “authorized for use in humans only” – a first for the organization in its efforts to protect overuse and abuse of critical first-line drugs that need to be protected by overuse in animal and plant health sectors – and consequent antimicrobial resistance (AMR). […] Continue reading -> Charting a New Course to Hepatitis Elimination in Pakistan 09/02/2024 Nida Ali Approximately 10 million Pakistanis are living with hepatitis C (HCV) with three people dying of HCV- related causes every minute – and this in the case of a disease that is now largely curable with treatment. Hepatitis B Virus (HBV) also poses major public health burden on the country’s health system with an estimated 4 […] Continue reading -> EXCLUSIVE: Reject Drug Procurement Secrecy, Civil Society Urges ‘Big Five’ Buyers 07/02/2024 Kerry Cullinan Over 50 civil society groups have written to the leaders of the world’s biggest medicine procurement programmes urging them to reject “secrecy clauses” in their agreements with pharmaceutical companies. The letter, which has been shared exclusively with Health Policy Watch, was sent to the heads of UNICEF, the Pan American Health Organization (PAHO), vaccine alliance […] Continue reading -> Soumya Swaminathan Returns to International Arena to Fight Air Pollution 01/02/2024 Chetan Bhattacharji Dr Soumya Swaminathan is returning to the international stage after leaving the World Health Organization (WHO) in late 2022, just as the world was recovering from the COVID-19 pandemic. She became the agency’s first Chief Scientist just before the pandemic, a position that propelled her to become a widely-known global voice for WHO, analyzing and […] Continue reading -> The Right to Health in Humanitarian Crises Needs to Encompass Non-Communicable Diseases 01/02/2024 Micaela Serafini, Katie Dain & Nicolai Haugaard The United Nations estimates that 363 million people are currently impacted by humanitarian crises driven by increasing fragility and conflict, the climate crisis and widening inequality. Around 108.4 million people were forced to flee their homes in 2022, meaning one in every 74 persons globally. Humanitarian crises, such as those occurring in Ukraine, Gaza, Libya, […] Continue reading -> The Campaign to Recognize Noma as an NTD: How Inclusion Can Drive Research to Prevent and Treat the Disease 31/01/2024 Maayan Hoffman A milestone World Health Organization (WHO) decision to recognise noma (cancrum oris or gangrenous stomatitis) as a neglected tropical disease (NTD) is the result of a longstanding campaign waged for over a decade by global health researchers and advocates in Geneva and beyond. Proponents believe that inclusion can offer noma’s victims the […] Continue reading -> Tackling Bias, Inequality, Lack of Privacy – New WHO Guidelines on AI Ethics and Governance are Released 19/01/2024 Zuzanna Stawiska WHO has released a novel set of guidelines on the ethics and governance of artificial intelligence (AI) in large multi-modal models (LMMs), a type of generative AI frequently used in healthcare. The guidelines include 40 recommendations for governments as well as other actors, such as technology companies and health care providers. Based on 2021 WHO […] Continue reading -> It Is Time to Streamline the Global HIV/AIDS Architecture 01/12/2023 Mukesh Kapila I endured a dreary weekend in a Paris hotel while others rushed home. As the junior English speaker of a task force of United Nations (UN) member states, it fell to me to finalise our report. It was the early 1990s and we had travelled across Asia, Africa and Latin America collating confusing evidence and […] Continue reading -> Posts navigation Older postsNewer posts
India Pushes Back To Protect Patient Access to Generic Medicines 15/02/2024 Disha Shetty PUNE, INDIA – Commerce minister Sunil Barthwal has clarified that India will not sign a new trade agreement with the European Free Trade Association (EFTA) that would limit access by the country’s thriving generic medicine industry to new drug formulations for critical diseases. India is currently negotiating a new trade deal with the EFTA, which […] Continue reading -> WHO Issues First-Ever List of Antimicrobials with Category “For Use in Humans Only” 13/02/2024 Sophia Samantaroy The WHO has released a first-ever list of 21 antimicrobials earmarked as “authorized for use in humans only” – a first for the organization in its efforts to protect overuse and abuse of critical first-line drugs that need to be protected by overuse in animal and plant health sectors – and consequent antimicrobial resistance (AMR). […] Continue reading -> Charting a New Course to Hepatitis Elimination in Pakistan 09/02/2024 Nida Ali Approximately 10 million Pakistanis are living with hepatitis C (HCV) with three people dying of HCV- related causes every minute – and this in the case of a disease that is now largely curable with treatment. Hepatitis B Virus (HBV) also poses major public health burden on the country’s health system with an estimated 4 […] Continue reading -> EXCLUSIVE: Reject Drug Procurement Secrecy, Civil Society Urges ‘Big Five’ Buyers 07/02/2024 Kerry Cullinan Over 50 civil society groups have written to the leaders of the world’s biggest medicine procurement programmes urging them to reject “secrecy clauses” in their agreements with pharmaceutical companies. The letter, which has been shared exclusively with Health Policy Watch, was sent to the heads of UNICEF, the Pan American Health Organization (PAHO), vaccine alliance […] Continue reading -> Soumya Swaminathan Returns to International Arena to Fight Air Pollution 01/02/2024 Chetan Bhattacharji Dr Soumya Swaminathan is returning to the international stage after leaving the World Health Organization (WHO) in late 2022, just as the world was recovering from the COVID-19 pandemic. She became the agency’s first Chief Scientist just before the pandemic, a position that propelled her to become a widely-known global voice for WHO, analyzing and […] Continue reading -> The Right to Health in Humanitarian Crises Needs to Encompass Non-Communicable Diseases 01/02/2024 Micaela Serafini, Katie Dain & Nicolai Haugaard The United Nations estimates that 363 million people are currently impacted by humanitarian crises driven by increasing fragility and conflict, the climate crisis and widening inequality. Around 108.4 million people were forced to flee their homes in 2022, meaning one in every 74 persons globally. Humanitarian crises, such as those occurring in Ukraine, Gaza, Libya, […] Continue reading -> The Campaign to Recognize Noma as an NTD: How Inclusion Can Drive Research to Prevent and Treat the Disease 31/01/2024 Maayan Hoffman A milestone World Health Organization (WHO) decision to recognise noma (cancrum oris or gangrenous stomatitis) as a neglected tropical disease (NTD) is the result of a longstanding campaign waged for over a decade by global health researchers and advocates in Geneva and beyond. Proponents believe that inclusion can offer noma’s victims the […] Continue reading -> Tackling Bias, Inequality, Lack of Privacy – New WHO Guidelines on AI Ethics and Governance are Released 19/01/2024 Zuzanna Stawiska WHO has released a novel set of guidelines on the ethics and governance of artificial intelligence (AI) in large multi-modal models (LMMs), a type of generative AI frequently used in healthcare. The guidelines include 40 recommendations for governments as well as other actors, such as technology companies and health care providers. Based on 2021 WHO […] Continue reading -> It Is Time to Streamline the Global HIV/AIDS Architecture 01/12/2023 Mukesh Kapila I endured a dreary weekend in a Paris hotel while others rushed home. As the junior English speaker of a task force of United Nations (UN) member states, it fell to me to finalise our report. It was the early 1990s and we had travelled across Asia, Africa and Latin America collating confusing evidence and […] Continue reading -> Posts navigation Older postsNewer posts
WHO Issues First-Ever List of Antimicrobials with Category “For Use in Humans Only” 13/02/2024 Sophia Samantaroy The WHO has released a first-ever list of 21 antimicrobials earmarked as “authorized for use in humans only” – a first for the organization in its efforts to protect overuse and abuse of critical first-line drugs that need to be protected by overuse in animal and plant health sectors – and consequent antimicrobial resistance (AMR). […] Continue reading -> Charting a New Course to Hepatitis Elimination in Pakistan 09/02/2024 Nida Ali Approximately 10 million Pakistanis are living with hepatitis C (HCV) with three people dying of HCV- related causes every minute – and this in the case of a disease that is now largely curable with treatment. Hepatitis B Virus (HBV) also poses major public health burden on the country’s health system with an estimated 4 […] Continue reading -> EXCLUSIVE: Reject Drug Procurement Secrecy, Civil Society Urges ‘Big Five’ Buyers 07/02/2024 Kerry Cullinan Over 50 civil society groups have written to the leaders of the world’s biggest medicine procurement programmes urging them to reject “secrecy clauses” in their agreements with pharmaceutical companies. The letter, which has been shared exclusively with Health Policy Watch, was sent to the heads of UNICEF, the Pan American Health Organization (PAHO), vaccine alliance […] Continue reading -> Soumya Swaminathan Returns to International Arena to Fight Air Pollution 01/02/2024 Chetan Bhattacharji Dr Soumya Swaminathan is returning to the international stage after leaving the World Health Organization (WHO) in late 2022, just as the world was recovering from the COVID-19 pandemic. She became the agency’s first Chief Scientist just before the pandemic, a position that propelled her to become a widely-known global voice for WHO, analyzing and […] Continue reading -> The Right to Health in Humanitarian Crises Needs to Encompass Non-Communicable Diseases 01/02/2024 Micaela Serafini, Katie Dain & Nicolai Haugaard The United Nations estimates that 363 million people are currently impacted by humanitarian crises driven by increasing fragility and conflict, the climate crisis and widening inequality. Around 108.4 million people were forced to flee their homes in 2022, meaning one in every 74 persons globally. Humanitarian crises, such as those occurring in Ukraine, Gaza, Libya, […] Continue reading -> The Campaign to Recognize Noma as an NTD: How Inclusion Can Drive Research to Prevent and Treat the Disease 31/01/2024 Maayan Hoffman A milestone World Health Organization (WHO) decision to recognise noma (cancrum oris or gangrenous stomatitis) as a neglected tropical disease (NTD) is the result of a longstanding campaign waged for over a decade by global health researchers and advocates in Geneva and beyond. Proponents believe that inclusion can offer noma’s victims the […] Continue reading -> Tackling Bias, Inequality, Lack of Privacy – New WHO Guidelines on AI Ethics and Governance are Released 19/01/2024 Zuzanna Stawiska WHO has released a novel set of guidelines on the ethics and governance of artificial intelligence (AI) in large multi-modal models (LMMs), a type of generative AI frequently used in healthcare. The guidelines include 40 recommendations for governments as well as other actors, such as technology companies and health care providers. Based on 2021 WHO […] Continue reading -> It Is Time to Streamline the Global HIV/AIDS Architecture 01/12/2023 Mukesh Kapila I endured a dreary weekend in a Paris hotel while others rushed home. As the junior English speaker of a task force of United Nations (UN) member states, it fell to me to finalise our report. It was the early 1990s and we had travelled across Asia, Africa and Latin America collating confusing evidence and […] Continue reading -> Posts navigation Older postsNewer posts
Charting a New Course to Hepatitis Elimination in Pakistan 09/02/2024 Nida Ali Approximately 10 million Pakistanis are living with hepatitis C (HCV) with three people dying of HCV- related causes every minute – and this in the case of a disease that is now largely curable with treatment. Hepatitis B Virus (HBV) also poses major public health burden on the country’s health system with an estimated 4 […] Continue reading -> EXCLUSIVE: Reject Drug Procurement Secrecy, Civil Society Urges ‘Big Five’ Buyers 07/02/2024 Kerry Cullinan Over 50 civil society groups have written to the leaders of the world’s biggest medicine procurement programmes urging them to reject “secrecy clauses” in their agreements with pharmaceutical companies. The letter, which has been shared exclusively with Health Policy Watch, was sent to the heads of UNICEF, the Pan American Health Organization (PAHO), vaccine alliance […] Continue reading -> Soumya Swaminathan Returns to International Arena to Fight Air Pollution 01/02/2024 Chetan Bhattacharji Dr Soumya Swaminathan is returning to the international stage after leaving the World Health Organization (WHO) in late 2022, just as the world was recovering from the COVID-19 pandemic. She became the agency’s first Chief Scientist just before the pandemic, a position that propelled her to become a widely-known global voice for WHO, analyzing and […] Continue reading -> The Right to Health in Humanitarian Crises Needs to Encompass Non-Communicable Diseases 01/02/2024 Micaela Serafini, Katie Dain & Nicolai Haugaard The United Nations estimates that 363 million people are currently impacted by humanitarian crises driven by increasing fragility and conflict, the climate crisis and widening inequality. Around 108.4 million people were forced to flee their homes in 2022, meaning one in every 74 persons globally. Humanitarian crises, such as those occurring in Ukraine, Gaza, Libya, […] Continue reading -> The Campaign to Recognize Noma as an NTD: How Inclusion Can Drive Research to Prevent and Treat the Disease 31/01/2024 Maayan Hoffman A milestone World Health Organization (WHO) decision to recognise noma (cancrum oris or gangrenous stomatitis) as a neglected tropical disease (NTD) is the result of a longstanding campaign waged for over a decade by global health researchers and advocates in Geneva and beyond. Proponents believe that inclusion can offer noma’s victims the […] Continue reading -> Tackling Bias, Inequality, Lack of Privacy – New WHO Guidelines on AI Ethics and Governance are Released 19/01/2024 Zuzanna Stawiska WHO has released a novel set of guidelines on the ethics and governance of artificial intelligence (AI) in large multi-modal models (LMMs), a type of generative AI frequently used in healthcare. The guidelines include 40 recommendations for governments as well as other actors, such as technology companies and health care providers. Based on 2021 WHO […] Continue reading -> It Is Time to Streamline the Global HIV/AIDS Architecture 01/12/2023 Mukesh Kapila I endured a dreary weekend in a Paris hotel while others rushed home. As the junior English speaker of a task force of United Nations (UN) member states, it fell to me to finalise our report. It was the early 1990s and we had travelled across Asia, Africa and Latin America collating confusing evidence and […] Continue reading -> Posts navigation Older postsNewer posts
EXCLUSIVE: Reject Drug Procurement Secrecy, Civil Society Urges ‘Big Five’ Buyers 07/02/2024 Kerry Cullinan Over 50 civil society groups have written to the leaders of the world’s biggest medicine procurement programmes urging them to reject “secrecy clauses” in their agreements with pharmaceutical companies. The letter, which has been shared exclusively with Health Policy Watch, was sent to the heads of UNICEF, the Pan American Health Organization (PAHO), vaccine alliance […] Continue reading -> Soumya Swaminathan Returns to International Arena to Fight Air Pollution 01/02/2024 Chetan Bhattacharji Dr Soumya Swaminathan is returning to the international stage after leaving the World Health Organization (WHO) in late 2022, just as the world was recovering from the COVID-19 pandemic. She became the agency’s first Chief Scientist just before the pandemic, a position that propelled her to become a widely-known global voice for WHO, analyzing and […] Continue reading -> The Right to Health in Humanitarian Crises Needs to Encompass Non-Communicable Diseases 01/02/2024 Micaela Serafini, Katie Dain & Nicolai Haugaard The United Nations estimates that 363 million people are currently impacted by humanitarian crises driven by increasing fragility and conflict, the climate crisis and widening inequality. Around 108.4 million people were forced to flee their homes in 2022, meaning one in every 74 persons globally. Humanitarian crises, such as those occurring in Ukraine, Gaza, Libya, […] Continue reading -> The Campaign to Recognize Noma as an NTD: How Inclusion Can Drive Research to Prevent and Treat the Disease 31/01/2024 Maayan Hoffman A milestone World Health Organization (WHO) decision to recognise noma (cancrum oris or gangrenous stomatitis) as a neglected tropical disease (NTD) is the result of a longstanding campaign waged for over a decade by global health researchers and advocates in Geneva and beyond. Proponents believe that inclusion can offer noma’s victims the […] Continue reading -> Tackling Bias, Inequality, Lack of Privacy – New WHO Guidelines on AI Ethics and Governance are Released 19/01/2024 Zuzanna Stawiska WHO has released a novel set of guidelines on the ethics and governance of artificial intelligence (AI) in large multi-modal models (LMMs), a type of generative AI frequently used in healthcare. The guidelines include 40 recommendations for governments as well as other actors, such as technology companies and health care providers. Based on 2021 WHO […] Continue reading -> It Is Time to Streamline the Global HIV/AIDS Architecture 01/12/2023 Mukesh Kapila I endured a dreary weekend in a Paris hotel while others rushed home. As the junior English speaker of a task force of United Nations (UN) member states, it fell to me to finalise our report. It was the early 1990s and we had travelled across Asia, Africa and Latin America collating confusing evidence and […] Continue reading -> Posts navigation Older postsNewer posts
Soumya Swaminathan Returns to International Arena to Fight Air Pollution 01/02/2024 Chetan Bhattacharji Dr Soumya Swaminathan is returning to the international stage after leaving the World Health Organization (WHO) in late 2022, just as the world was recovering from the COVID-19 pandemic. She became the agency’s first Chief Scientist just before the pandemic, a position that propelled her to become a widely-known global voice for WHO, analyzing and […] Continue reading -> The Right to Health in Humanitarian Crises Needs to Encompass Non-Communicable Diseases 01/02/2024 Micaela Serafini, Katie Dain & Nicolai Haugaard The United Nations estimates that 363 million people are currently impacted by humanitarian crises driven by increasing fragility and conflict, the climate crisis and widening inequality. Around 108.4 million people were forced to flee their homes in 2022, meaning one in every 74 persons globally. Humanitarian crises, such as those occurring in Ukraine, Gaza, Libya, […] Continue reading -> The Campaign to Recognize Noma as an NTD: How Inclusion Can Drive Research to Prevent and Treat the Disease 31/01/2024 Maayan Hoffman A milestone World Health Organization (WHO) decision to recognise noma (cancrum oris or gangrenous stomatitis) as a neglected tropical disease (NTD) is the result of a longstanding campaign waged for over a decade by global health researchers and advocates in Geneva and beyond. Proponents believe that inclusion can offer noma’s victims the […] Continue reading -> Tackling Bias, Inequality, Lack of Privacy – New WHO Guidelines on AI Ethics and Governance are Released 19/01/2024 Zuzanna Stawiska WHO has released a novel set of guidelines on the ethics and governance of artificial intelligence (AI) in large multi-modal models (LMMs), a type of generative AI frequently used in healthcare. The guidelines include 40 recommendations for governments as well as other actors, such as technology companies and health care providers. Based on 2021 WHO […] Continue reading -> It Is Time to Streamline the Global HIV/AIDS Architecture 01/12/2023 Mukesh Kapila I endured a dreary weekend in a Paris hotel while others rushed home. As the junior English speaker of a task force of United Nations (UN) member states, it fell to me to finalise our report. It was the early 1990s and we had travelled across Asia, Africa and Latin America collating confusing evidence and […] Continue reading -> Posts navigation Older postsNewer posts
The Right to Health in Humanitarian Crises Needs to Encompass Non-Communicable Diseases 01/02/2024 Micaela Serafini, Katie Dain & Nicolai Haugaard The United Nations estimates that 363 million people are currently impacted by humanitarian crises driven by increasing fragility and conflict, the climate crisis and widening inequality. Around 108.4 million people were forced to flee their homes in 2022, meaning one in every 74 persons globally. Humanitarian crises, such as those occurring in Ukraine, Gaza, Libya, […] Continue reading -> The Campaign to Recognize Noma as an NTD: How Inclusion Can Drive Research to Prevent and Treat the Disease 31/01/2024 Maayan Hoffman A milestone World Health Organization (WHO) decision to recognise noma (cancrum oris or gangrenous stomatitis) as a neglected tropical disease (NTD) is the result of a longstanding campaign waged for over a decade by global health researchers and advocates in Geneva and beyond. Proponents believe that inclusion can offer noma’s victims the […] Continue reading -> Tackling Bias, Inequality, Lack of Privacy – New WHO Guidelines on AI Ethics and Governance are Released 19/01/2024 Zuzanna Stawiska WHO has released a novel set of guidelines on the ethics and governance of artificial intelligence (AI) in large multi-modal models (LMMs), a type of generative AI frequently used in healthcare. The guidelines include 40 recommendations for governments as well as other actors, such as technology companies and health care providers. Based on 2021 WHO […] Continue reading -> It Is Time to Streamline the Global HIV/AIDS Architecture 01/12/2023 Mukesh Kapila I endured a dreary weekend in a Paris hotel while others rushed home. As the junior English speaker of a task force of United Nations (UN) member states, it fell to me to finalise our report. It was the early 1990s and we had travelled across Asia, Africa and Latin America collating confusing evidence and […] Continue reading -> Posts navigation Older postsNewer posts
The Campaign to Recognize Noma as an NTD: How Inclusion Can Drive Research to Prevent and Treat the Disease 31/01/2024 Maayan Hoffman A milestone World Health Organization (WHO) decision to recognise noma (cancrum oris or gangrenous stomatitis) as a neglected tropical disease (NTD) is the result of a longstanding campaign waged for over a decade by global health researchers and advocates in Geneva and beyond. Proponents believe that inclusion can offer noma’s victims the […] Continue reading -> Tackling Bias, Inequality, Lack of Privacy – New WHO Guidelines on AI Ethics and Governance are Released 19/01/2024 Zuzanna Stawiska WHO has released a novel set of guidelines on the ethics and governance of artificial intelligence (AI) in large multi-modal models (LMMs), a type of generative AI frequently used in healthcare. The guidelines include 40 recommendations for governments as well as other actors, such as technology companies and health care providers. Based on 2021 WHO […] Continue reading -> It Is Time to Streamline the Global HIV/AIDS Architecture 01/12/2023 Mukesh Kapila I endured a dreary weekend in a Paris hotel while others rushed home. As the junior English speaker of a task force of United Nations (UN) member states, it fell to me to finalise our report. It was the early 1990s and we had travelled across Asia, Africa and Latin America collating confusing evidence and […] Continue reading -> Posts navigation Older postsNewer posts
Tackling Bias, Inequality, Lack of Privacy – New WHO Guidelines on AI Ethics and Governance are Released 19/01/2024 Zuzanna Stawiska WHO has released a novel set of guidelines on the ethics and governance of artificial intelligence (AI) in large multi-modal models (LMMs), a type of generative AI frequently used in healthcare. The guidelines include 40 recommendations for governments as well as other actors, such as technology companies and health care providers. Based on 2021 WHO […] Continue reading -> It Is Time to Streamline the Global HIV/AIDS Architecture 01/12/2023 Mukesh Kapila I endured a dreary weekend in a Paris hotel while others rushed home. As the junior English speaker of a task force of United Nations (UN) member states, it fell to me to finalise our report. It was the early 1990s and we had travelled across Asia, Africa and Latin America collating confusing evidence and […] Continue reading -> Posts navigation Older postsNewer posts
It Is Time to Streamline the Global HIV/AIDS Architecture 01/12/2023 Mukesh Kapila I endured a dreary weekend in a Paris hotel while others rushed home. As the junior English speaker of a task force of United Nations (UN) member states, it fell to me to finalise our report. It was the early 1990s and we had travelled across Asia, Africa and Latin America collating confusing evidence and […] Continue reading -> Posts navigation Older postsNewer posts